PDCD1LG2 and neoplasm: Mice lacking CD8+ T cells were unable to control PD-L2 KO tumors after chemotherapy, while control animals or mice treated with anti-CD4-depleting antibodies had robust suppression of tumor growth (Fig. 2d).